“I believe that Dr. Andrew von Eschenbach has the qualifications needed to serve as head of the FDA. As a former researcher, physician and cancer survivor Dr. von Eschenbach brings a unique background and perspective to this position.
“While I remain deeply concerned about how the FDA handled the over-the-counter application of Plan B and urge the agency to revisit the issue of age restrictions, I appreciate Dr. von Eschenbach’s movement on a decision. The approval of Plan B marks real progress for millions of American women and a step toward rebuilding the credibility of the FDA.
“I have always supported a strong and independent FDA. It is the only way in which the agency can truly operate effectively and with the confidence of American consumers and health care providers.
“As we work to improve drug safety and begin the process of reauthorizing critical legislation I hope that Dr. von Eschenbach will continue to provide the strong scientific leadership the FDA needs and deserves.”
English 
Spanish